Initial Insights From JUPITER-02 - Toripalimab Efficacy in R/M NPC | OncLive
Initial Insights From JUPITER-02 - Toripalimab Efficacy in R/M NPC | …
2 weeks ago
onclive.com
Targeting Recurrent and Metastatic NPC With Systemic Immunotherapy: The Role of Toripalimab and Insights From Radiation Oncology | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Targeting Recurrent and Metastatic NPC With Systemic Immunotherap…
11 months ago
targetedonc.com
Toripalimab Combo Delivers Long-Term Efficacy in Nasopharyngeal Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Toripalimab Combo Delivers Long-Term Efficacy in Nasopharyngeal …
10 months ago
targetedonc.com
Junshi Biosciences Announces Approval of sNDA for Toripalimab in Combination with Bevacizumab for 1st-line Treatment of Advanced Hepatocellular Carcinoma
Junshi Biosciences Announces Approval of sNDA for Toripalimab …
11 months ago
thespec.com
Treatment Landscape of Recurrent NPC: Evaluating First-Line Toripalimab in the Recurrent Setting | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Treatment Landscape of Recurrent NPC: Evaluating First-Line Toripal…
11 months ago
targetedonc.com
Proud to announce the launch of Toripalimab in India, the first and only immuno-oncology drug approved by various regulatory authorities around the world such as the USFDA, DCGI, EMA, MHRA and others for the treatment of adults with recurrent or metastatic nasopharyngeal carcinoma (RM-NPC). Toripalimab is a New Biological Entity (NBE). The combination of Toripalimab and standard of care chemotherapy has shown a 48% reduction in risk of progression or death, meeting a significant unmet need for p
0:18
Proud to announce the launch of Toripalimab in India, the first and …
194 viewsNov 28, 2024
FacebookDr. Reddy's Laboratories Ltd.
Dr Yuan on 3-Year Data for Perioperative Toripalimab/Chemo in Gastric/GEJ Cancer | OncLive
Dr Yuan on 3-Year Data for Perioperative Toripalimab/Chemo …
1 month ago
onclive.com
Phase II Trial Results of Disitamab Vedotin and Toripalimab Combina…
11 months ago
urotoday.com
Junshi Biosciences Announces Toripalimab's NDA Accepted by th…
Feb 2, 2024
finanznachrichten.de
Dr. Rapisuwon on the Potential Utility of Toripalimab in Melanom…
May 4, 2021
onclive.com
Toripalimab FLOT Regimen Improves Gastric Cancer Outcome…
19.9K views1 month ago
linkedin.com
6:26
LOQTORZI (toripalimab) : Nouveau traitement pour le carcinome naso…
1 week ago
YouTubePharmaide
4:56
Subcutaneous Toripalimab: Promising NSCLC Treatment | No…
2 months ago
YouTubeThe Daily Wave
5:28
What Is The Moa Of Loqtorzi Toripalimab
73 viewsJul 18, 2024
YouTubeRX Card Club
5:40
ASCO 2026 update l Is Toripalimab the GAME CHANGER for Resectab…
549 views1 month ago
YouTubeEdusurg Clinics
4:58
Toripalimab plus chemotherapy improves 3-year survival in resect…
1 month ago
Vimeoecancer
6:15
GFH018 and toripalimab combination therapy for previousl…
Oct 27, 2014
jove.com
12:19
Monoclonal Antibody for Severe Chronic Rhinosinusitis, Toripalim…
204 views6 months ago
YouTubeJAMA Network
Coherus BioSciences obtient l'examen prioritaire de la FDA pou…
7 months ago
zonebourse.com
6:13
Toripalimab plus metronomic chemotherapy show efficacy in tre…
276 viewsFeb 20, 2024
YouTubeecancer
1:26
Toripalimab #How is it different
77 views4 months ago
YouTubeCancer education made simple # Chandrakant…
China’s new cancer drug Toripalimab is approved in the US …
Nov 29, 2023
South China Morning PostVictoria Bela
8:24
RENOTORCH Phase III: Toripalimab + Axitinib vs Sunitinib in Advance…
26 views6 months ago
YouTubeCancer Research and Statistic Foundation
6:09
DIAMOND: toripalimab & radiotherapy in nasopharyngeal c…
326 views8 months ago
YouTubeVJOncology
3:23
Pratiek Paatil | 💉 नई दवा | नई उम्मीद | नई ज़िंदगी 🌸 Toripali…
38.1K views6 months ago
Instagramthecancerdoctor10
1:33
RC48-C016: disitamab vedotin & toripalimab vs chemotherapy in H…
82 views4 months ago
YouTubeVJOncology
4:12
Chidamide plus toripalimab shows promise in advanced sarcoma
70 views4 months ago
YouTubeVJOncology
2:22
NEOTORCH Trial: Perioperative Toripalimab for NSCLC - OncTalk …
106 viewsApr 2, 2024
YouTubeGlobal Resource for Advancing Cancer Education
2:52
New cancer medicine Immunotherapy for Head & Neck, …
5.1K viewsDec 17, 2024
YouTubeDr. Pratik Patil Oncologist
6:10
FDA-approved Chinese cancer drug to cost 30 times more
Dec 12, 2023
South China Morning PostVictoria Bela, Nick Dearman
See more videos
Static thumbnail place holder